Peripartum Cardiomyopathy: JACC State-of-the-Art Review

Highlights •Medications used to treat HF during pregnancy and lactation require special considerations. •Severe HF may require advanced therapies and mechanical circulatory support. •Subsequent pregnancies carry risk of relapse, and dedicated counseling and monitoring are essential. •Future research about long-term outcomes, continued drug therapy, use of bromocriptine, device therapy, and genetics are needed.